Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study of ABT-263 in Combination With Dose-Intensive Rituximab, or Dose-Intensive Rituximab Alone, in Previously Untreated Patients With B-Cell, Chronic Lymphocytic Leukemia (CLL)

ClinicalTrials.gov ID: NCT01087151

Public ClinicalTrials.gov record NCT01087151. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Multicenter, Randomized, Controlled, Open-label Study of the Safety, Efficacy and Pharmacokinetics of ABT-263 in Combination With Dose-intensive Rituximab, or Dose-intensive Rituximab Alone, in Previously Untreated Patients With B-Cell, Chronic Lymphocytic Leukemia (CLL)

Study identification

NCT ID
NCT01087151
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Genentech, Inc.
Industry
Enrollment
118 participants

Conditions and interventions

Interventions

  • ABT-263 Drug
  • rituximab Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2010
Primary completion
May 31, 2012
Completion
May 31, 2012
Last update posted
Nov 1, 2016

2010 – 2012

United States locations

U.S. sites
48
U.S. states
18
U.S. cities
41
Facility City State ZIP Site status
Not listed Alhambra California 91801
Not listed Antioch California 94531
Not listed Berkeley California 94704
Not listed Burbank California 91505
Not listed Duarte California 91010
Not listed Dublin California 94568
Not listed La Jolla California 92093
Not listed Los Angeles California 90024
Not listed Los Angeles California 90073
Not listed Los Angeles California 90095-1772
Not listed Los Angeles California 90095
Not listed Northridge California 91325
Not listed Pleasant Hill California 94523
Not listed San Leandro California 94578-2626
Not listed San Luis Obispo California 93454
Not listed Santa Monica California 90404
Not listed Fort Collins Colorado 80528
Not listed Norwalk Connecticut 06856
Not listed Bay Pines Florida 33744
Not listed Atlanta Georgia 30322
Not listed Chicago Illinois 60612
Not listed Decatur Illinois 62526
Not listed Harvey Illinois 60426
Not listed Tinley Park Illinois 60477
Not listed Shreverport Louisiana 71103
Not listed Baltimore Maryland 21215
Not listed Bethesda Maryland 20817
Not listed Bethesda Maryland 20874
Not listed Randallstown Maryland 21133
Not listed Lansing Michigan 48909
Not listed Lansing Michigan 48912
Not listed Omaha Nebraska 68114
Not listed Henderson Nevada 89052
Not listed Las Vegas Nevada 89148
Not listed Las Vegas Nevada 89169
Not listed Reno Nevada 89502
Not listed Cherry Hill New Jersey 08003
Not listed Farmington New Mexico 87401
Not listed Oneida New York 13421
Not listed Oswego New York 13126
Not listed Syracuse New York 13210
Not listed Middletown Ohio 45042
Not listed Philadelphia Pennsylvania 19111
Not listed Pittsburgh Pennsylvania 15224
Not listed Corpus Christi Texas 78405
Not listed Lubbock Texas 79410
Not listed Lubbock Texas 79415
Not listed Everett Washington 98201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 55 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01087151, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2016 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01087151 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →